• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Latterell Venture Partners

edit

Latterell Venture Partners invests in early stage healthcare companies with innovative technologies, large market opportunities, and passionate entrepreneurs. We offer a unique blend of venture capital, entrepreneurial, technical, clinical and collaborative skills which enable us to help entrepreneurs create highly successful new startups. LVP is committed to building a portfolio of outstanding biotechnology and medical device companies which produce excellent returns for our limited partners while providing major new disease treatments to help patients worldwide.

Recent Milestones

edit

• 
  Latterell Venture Partners invested in Naurex. (12/17/12)
  Posted 12/17/12 at 7:20pm via fiercebiotech.com
• 
  Latterell Venture Partners invested in HemaQuest Pharmaceuticals. (3/12/12)
  Posted 3/12/12 at 7:53pm via hemaquest.com
• 
  Latterell Venture Partners invested in Neuraltus Pharmaceuticals. (1/31/12)
  Posted 1/31/12 at 6:19pm via onbiovc.com
• 
  Latterell Venture Partners invested in Transcend Medical. (1/17/12)
  Posted 1/17/12 at 2:57am via onbiovc.com
• 
  Latterell Venture Partners invested in Inova Labs. (11/9/11)
  Posted 11/8/11 at 7:55pm via sec.gov
• 
  Latterell Venture Partners invested in Naurex. (5/11/11)
  Posted 5/11/11 at 7:32pm via fiercebiotech.com
• 
  Latterell Venture Partners invested in ProteinSimple. (10/14/10)
  Posted 10/22/10 at 4:00am via xconomy.com
• 
  Latterell Venture Partners invested in Femta Pharmaceuticals. (10/12/10)
  Posted 10/12/10 at 5:33pm via onbiovc.com
• 
  Latterell Venture Partners invested in TetraLogic Pharmaceuticals. (8/10/10)
  Posted 8/10/10 at 5:26pm via fiercebiotech.com
• 
  Latterell Venture Partners invested in Calistoga Pharmaceuticals. (6/30/10)
  Posted 6/30/10 at 5:59pm via calistogapharma.com
• 
  Latterell Venture Partners invested in Pulmonx. (3/8/10)
  Posted 3/8/10 at 2:54pm via onbiovc.com
• 
  Latterell Venture Partners invested in Femta Pharmaceuticals. (7/17/09)
  Posted 9/29/09 at 7:08am via socaltech.com
• 
  Latterell Venture Partners invested in Transcend Medical. (6/1/09)
  Posted 6/9/09 at 9:21pm via fiercebiotech.com
• 
  Latterell Venture Partners invested in ProteinSimple. (4/10/09)
  Posted 4/10/09 at 6:30am via pehub.com
• 
  Latterell Venture Partners invested in Neuraltus Pharmaceuticals. (3/26/09)
  Posted 1/31/12 at 6:19pm via neuraltus.com
• 
  Latterell Venture Partners invested in Pathway Medical Technologies. (3/1/09)
  Posted 4/13/09 at 1:51pm via venturebeat.com

Investments

Videos

Sources

1. Naurex Completes $38 Million Series B Financing (fiercebiotech.com) [edit]
2. HemaQuest Pharmaceuticals Raises $13 Million in Series B Extension Financing (hemaquest.com) [edit]
3. Neuraltus Pharmaceuticals, Inc.: Series B $9.6M (onbiovc.com) [edit]
4. Transcend Medical, Inc.: Series B $16M (onbiovc.com) [edit]
5. SEC (sec.gov) [edit]
6. Naurex raises $18M for Ph2 depression program (fiercebiotech.com) [edit]
7. Cell Biosciences Nabs $20M (xconomy.com) [edit]
8. Femta Pharmaceuticals, Inc.: Series A $22M (onbiovc.com) [edit]
9. TetraLogic nabs $32M round for lead cancer therapy Read more: TetraLogic nabs $32M round for lead cancer therapy (fiercebiotech.com) [edit]
10. Calistoga Pharmaceuticals Raises $40 Million in Series C Financing (calistogapharma.com) [edit]
11. Pulmonx, Inc.: Series C $32M (onbiovc.com) [edit]
12. Femta Pharmaceuticals Raises $1M (socaltech.com) [edit]
13. Transcend Medical pockets $35M in VC (fiercebiotech.com) [edit]
14. Cell Biosciences Raises $10 Million (pehub.com) [edit]
15. Neuraltus Pharmaceuticals Raises $17 Million Series A Funding (neuraltus.com) [edit]
16. Pathway Medical lands generous $40M to treat arterial disease (venturebeat.com) [edit]
17. OncoMed Pharmaceuticals, Inc. Completes $154 Million Series B Financing (biospace.com) [edit]
18. Talima Therapeutics raises $19M for site-specific drugs (venturebeat.com) [edit]
19. Lung-device maker Pulmonx draws in $20M (venturebeat.com) [edit]
20. Ovalis, Inc.: Series B $6.6M (onbiovc.com) [edit]
21. Bio-Medicine (bio-medicine.org) [edit]